How Do Cardiac MRI and PET-CT Find Active Inflammation in Cardiac Sarcoidosis?

The rhythm strip came back first. A 41-year-old runner, in for a routine check, had a heart that paused between beats in a way it shouldn’t. Then the chest X-ray showed swollen lymph nodes near the airways. Two unrelated findings, or one disease hiding in two places? The cardiologist’s next sentence was the one nobody expects to hear: “I’d like to arrange a cardiac sarcoidosis PET scan, and a cardiac MRI.”

For most people, this is the first time those words have been strung together. Sarcoidosis sounds like something that happens to lungs. PET scans sound like something that happens to people with cancer. Put them together and the imagination fills the gaps with worst cases.

The reality is quieter and more interesting. Two very different machines, one that listens to the magnetism of water in tissue and one that follows a sugar molecule through the body, each answer a question the other can’t. This is how they work, what the day involves, and why the diet sheet you’re handed matters more than you’d think.

Why would a cardiologist order a cardiac sarcoidosis PET scan?

Cardiologists order imaging when the heart is behaving in a way that ordinary explanations don’t cover. A young person with heart block, a run of ventricular tachycardia in someone with clean coronary arteries, or a weakened pumping chamber with no history of heart attack: each raises the possibility that something is inflaming the muscle itself rather than blocking its blood supply.

Sarcoidosis is one of those somethings. It is a disease in which the immune system forms small clusters of inflammatory cells, called granulomas, in organs where they don’t belong. When granulomas settle in the heart’s wiring or walls, they can slow the electrical signal, trigger abnormal rhythms, or leave scar behind as they heal (Cleveland Clinic).

A cardiac sarcoidosis PET scan is designed to catch those granulomas while they are still active. The heart is not the only target. Because the scan usually covers the whole body, it can reveal sarcoidosis in lymph nodes, lungs or skin at the same time, sometimes offering a safer place to take a biopsy than the heart itself (HRS expert consensus, PubMed).

So the honest answer to “why me?” is usually not that your doctor suspects the worst. The scan is a way of testing a specific idea, that inflammation rather than plaque is disturbing the heart, and of avoiding a treatment path that would be wrong if the idea turns out to be false. Ordering a PET scan says more about the quality of the question than the severity of the answer.

What is cardiac sarcoidosis, and is it serious?

Sarcoidosis can affect almost any organ, but the lungs and lymph nodes carry the load most often. The heart is involved less frequently, and when it is, the disease is often silent. Cleveland Clinic notes that cardiac sarcoidosis is recognized during life in roughly 5% of people with sarcoidosis, yet autopsy studies find heart involvement in a considerably larger share, which tells you how easily it hides (Cleveland Clinic).

Is it serious? It can be, and it can also be manageable. The seriousness depends on where the granulomas sit. Inflammation in the conduction system may cause heart block, a slowing or interruption of the electrical signal traveling from the upper to the lower chambers. Inflammation or scar in the ventricle walls can create the electrical short-circuits behind ventricular arrhythmias. Widespread involvement can weaken the pumping function over time (Mayo Clinic).

What makes early imaging valuable is the distinction between active inflammation and old scar. Active granulomas may respond to medicines that dampen the immune system. Scar does not; it is a healed wound, and the questions it raises are about rhythm protection rather than immune suppression. A patient whose heart shows inflammation but little scar faces a different conversation from one whose heart shows the reverse.

Many people with sarcoidosis never develop heart involvement at all, and the disease in other organs sometimes settles on its own (NHS). The purpose of the two scans is to find out which situation applies to you, not to assume the gravest one.

How does cardiac MRI find scar and inflammation in sarcoidosis?

Cardiac MRI, or magnetic resonance imaging of the heart, builds pictures from the way hydrogen atoms in water and fat respond to a strong magnetic field and radio pulses. No radiation is involved (MedlinePlus). The scanner captures the heart moving through its cycle, measures the size and squeeze of each chamber, and then, after an injection of a gadolinium-based contrast agent, looks for places where the contrast lingers.

That lingering is the key. Healthy, tightly packed muscle cells push the contrast out quickly. Scar tissue, with its loose collagen and expanded space between cells, holds onto it. On the images taken several minutes after injection, scarred areas glow bright against dark, healthy muscle. Radiologists call this late gadolinium enhancement.

In sarcoidosis, the pattern of that glow is a clue in itself. Heart attacks scar the inner lining of the wall in the territory of one artery. Sarcoid granulomas tend to leave patchy marks in the middle or outer layers, often in the septum between the ventricles or along the base of the heart, in places no single artery would explain (HRS expert consensus, PubMed).

MRI can also hint at active swelling. Sequences that are sensitive to water content, known as T2-weighted or T2-mapping images, brighten where tissue holds extra fluid, a sign of inflammation. This is less specific than the PET signal, and a heart can look swollen for reasons other than sarcoidosis, which is one reason the two tests are so often ordered together rather than as alternatives.

How does an FDG PET scan light up active inflammation in cardiac sarcoidosis?

Positron emission tomography follows a tracer, a molecule tagged with a tiny amount of radioactivity, as it moves through the body. The camera detects where the tracer collects and the CT component, an X-ray scan taken in the same session, provides an anatomical map to lay that signal over (MedlinePlus).

The tracer used for sarcoidosis is fluorodeoxyglucose, or FDG, a modified sugar. Cells take it up in proportion to how hungrily they are burning glucose. Activated inflammatory cells inside a granuloma are among the hungriest cells in the body. Where they cluster, FDG accumulates, and the image shows a focal bright spot in the heart wall.

The catch is that the normal heart also loves glucose. On an ordinary day, healthy muscle would soak up FDG everywhere and drown the signal from a few granulomas. The entire preparation for a cardiac sarcoidosis PET scan is built around switching the heart’s fuel from sugar to fat so that only inflammatory cells, which cannot make that switch, keep glowing. That is why the diet you are handed is not a formality.

Most protocols pair the FDG images with a perfusion scan using a second tracer that maps blood flow at rest. Reading the two side by side allows a recognizable pattern to emerge: an area with reduced blood flow and intense FDG uptake suggests active inflammation with early damage, while an area with reduced flow and no uptake points to established scar (HRS expert consensus, PubMed). Uniform uptake across the whole heart, by contrast, usually means the diet didn’t fully work and the study may need repeating.

Why the PET scan diet for cardiac sarcoidosis matters so much

Ask an imaging team what most often spoils a cardiac sarcoidosis PET scan, and the answer is rarely the machine. It is a slice of toast.

The preparation aims to put the heart into a fat-burning state. Two levers do this. The first is a diet high in fat and very low in carbohydrate before the scan, so the heart’s usual sugar supply dries up and it turns to fatty acids instead. The second is a prolonged fast right before the appointment, which keeps insulin low and stops any last-minute glucose from reaching the muscle. Protocols vary; the dietary phase may cover a single meal or a full day, and the fast commonly runs for a number of hours beyond the usual few required for a standard PET (HRS expert consensus, PubMed; MedlinePlus). Your imaging department’s written instructions override anything you read elsewhere, including this article.

In practice, “high-fat, low-carb” means eggs, meat, fish, cheese, oils and non-starchy vegetables, and it means avoiding bread, rice, pasta, fruit, sweetened drinks, milk, and the hidden sugars in sauces and processed foods. Some departments also give an anticoagulant injection shortly before the tracer to nudge free fatty acids upward. That is a clinical decision made by the imaging team, based on your other conditions.

Diabetes complicates the picture, because glucose control and insulin timing interact with the preparation. Tell the department in advance; they will usually adjust the plan rather than skip the scan. Hidden carbohydrate matters too: a “sugar-free” gum, a splash of milk in coffee, or a protein bar can be enough to leave the whole heart glowing and the images unreadable. When that happens, the study is often repeated, so a careful day beforehand saves a second visit.

What actually happens on the day of a cardiac sarcoidosis PET scan

You arrive fasted and, ideally, having followed the diet to the letter. A technologist reviews what you ate, checks your blood glucose with a finger-prick, and places a small cannula in an arm vein. If the perfusion scan is part of your protocol, that usually comes first: a short-lived tracer is injected and the camera images blood flow through the heart muscle over a few minutes.

Then comes the FDG. After the injection there is a waiting period, commonly an hour or so, while the tracer distributes. You rest in a quiet room. Staff will ask you to stay still and warm, because shivering muscle takes up sugar and can muddy the picture. Reading is fine; a brisk walk is not.

The scan itself is painless. You lie on a narrow table that slides through a ring-shaped scanner, arms usually above your head. The CT portion takes seconds. The PET portion of the heart takes longer, and a whole-body sweep to look for sarcoidosis elsewhere adds time on top. All told, expect to be in the department for a few hours, though the time under the camera is a fraction of that (MedlinePlus).

Afterward, you can eat normally, and most people go straight back to their day. The tracer’s radioactivity fades within hours; drinking water helps clear it. Departments often suggest limiting close, prolonged contact with infants and pregnant people for the rest of that day as a precaution. Results are not read on the spot. A nuclear medicine physician or cardiologist compares the FDG images to the perfusion images, checks whether the diet suppressed normal uptake, and writes a report that reaches your cardiologist, typically within days to a week or two depending on the service.

Cardiac MRI vs PET-CT for sarcoidosis: what each test can and cannot show

People often assume one of these scans is simply the better version of the other. They are closer to two witnesses describing the same event from different windows.

Question	Cardiac MRI	FDG PET-CT
What does it detect best?	Scar (late gadolinium enhancement), chamber size and pumping function, tissue swelling	Active inflammation via glucose-hungry cells; blood-flow defects with paired perfusion tracer
Radiation	None	Small dose from tracer and CT
Contrast or tracer	Gadolinium-based agent	FDG, plus a perfusion tracer in most protocols
Preparation	Usually minimal; kidney function check for contrast	Strict high-fat, low-carbohydrate diet and prolonged fast
Looks outside the heart?	Not in a standard cardiac study	Yes; whole-body imaging can reveal other sarcoid sites and biopsy targets
Tracks treatment response?	Limited; scar does not regress	Yes; falling FDG uptake suggests inflammation is settling
Common limitations	Implanted devices may cause artifact or be unsuitable; claustrophobia; severe kidney disease	Failed dietary suppression; cannot see scar directly; small lesions may be missed

The clinical logic follows from the table. MRI is often the first test when a heart has an unexplained rhythm problem, because it shows scar with detail and involves no radiation (MedlinePlus). PET-CT answers the follow-up question MRI cannot: is anything still burning? And once treatment starts, PET is the tool that can be repeated to see whether the fire is going out (HRS expert consensus, PubMed).

Neither replaces a biopsy where one is feasible, and neither is read in isolation from your ECG, echocardiogram and history. The strength lies in the overlap.

Who is usually offered these scans, and who is asked to wait

Guidelines describe two broad groups for whom cardiac imaging is reasonable. The first is people already known to have sarcoidosis somewhere else who develop a cardiac warning sign: palpitations, fainting, new heart block, an abnormal ECG or echocardiogram. The second is people with no sarcoidosis history whose heart problem is unusual enough to suggest it, such as heart block in someone under 60 with no other explanation, or ventricular tachycardia with normal coronary arteries (HRS expert consensus, PubMed).

Screening everyone with sarcoidosis by MRI or PET is not the usual practice. The consensus approach is to ask about symptoms and check an ECG, then move to advanced imaging when something points toward the heart. A person with stable lung sarcoidosis, no symptoms and a normal ECG is more often followed with routine checks than sent for a PET scan.

Some people are asked to wait or to have a different test. Standard MRI may be unsuitable for those with older, non-MRI-conditional implanted devices, certain metal fragments, or severe kidney impairment that makes gadolinium contrast unwise (MedlinePlus). Pregnancy generally leads clinicians to postpone PET-CT because of the radiation, and to weigh MRI carefully. Uncontrolled diabetes may delay a PET scan until glucose can be managed around the preparation. A recent large carbohydrate meal, or a diet that wasn’t followed, usually means rescheduling rather than proceeding with images that will not be interpretable.

The decision about who is scanned and when sits with the cardiology and imaging teams, who balance what the images could change against the effort and small risks of getting them.

How doctors combine imaging into a cardiac sarcoidosis diagnosis

A bright spot on a scan is not a diagnosis. The most widely used framework, from the Heart Rhythm Society expert consensus, offers two routes. The first is tissue: granulomas found in a heart muscle biopsy with no other cause. The second is clinical, and it is the route most people take, because heart biopsies sample only tiny pieces and often miss patchy disease (HRS expert consensus, PubMed).

The clinical route requires two things. Sarcoidosis must be proven by biopsy somewhere else in the body, a lymph node or the lung most often. Then at least one cardiac feature must be present, and imaging supplies several of the candidates: patchy FDG uptake on a PET scan performed with proper preparation, late gadolinium enhancement on MRI in a pattern consistent with sarcoidosis, or a heart block or arrhythmia that responds to immune-suppressing treatment.

This is where the whole-body part of the PET matters. A patient with heart block and a suspicious MRI but no known sarcoidosis has a gap in the evidence. If the PET reveals an FDG-avid lymph node in the chest, that node can be biopsied through a bronchoscope, a far less invasive procedure than sampling the heart. Positive tissue closes the loop.

Other conditions can mimic the pictures. Giant cell myocarditis, other forms of myocarditis, and some inherited heart muscle diseases can leave scar in similar places. Certain cancers and infections also take up FDG. The imaging report will usually describe findings as “consistent with” or “suggestive of” rather than “diagnostic,” and that caution is deliberate. Your team weighs the scans against everything else before settling on a name for what is happening.

What the days and weeks after the scans usually look like

The first stretch after imaging is mostly waiting, and it helps to know what the waiting is for.

Reports are typically finalized within days to a couple of weeks, depending on whether the images go to a multidisciplinary meeting where cardiologists, radiologists, nuclear medicine physicians and often respiratory or rheumatology specialists review complex cases together. If a biopsy target was found, arranging that procedure and waiting for pathology adds further time. None of this delay means bad news; it usually means the team wants a full picture before committing to a plan.

Once results are in, the conversation tends to branch. If the scans show active inflammation, the team may discuss medicines that suppress the immune response. Corticosteroids are the class most often used first, with other immunosuppressant classes considered when steroids need to be reduced or are not suitable (Mayo Clinic). These medicines work by damping the activity of the immune cells forming granulomas. Whether to start one, which, and for how long are decisions for the prescribing clinician, who weighs your heart findings against side effects and other health conditions.

If the scans show scar or a conduction problem, the discussion may turn to rhythm protection: a pacemaker for heart block, or an implantable defibrillator where the risk of dangerous arrhythmia is judged high. Guidelines set out the situations in which each is considered, and the choice depends on details specific to your heart (HRS expert consensus, PubMed).

Between appointments, most people are asked to continue their usual activities, report new symptoms promptly, and, if treatment begins, expect a follow-up PET scan some months later to gauge the response.

How a follow-up PET scan tracks whether treatment is working

Here lies PET’s quiet advantage. Scar on an MRI is permanent; once formed, it looks much the same year after year. Inflammation on a PET scan is dynamic. Granulomas that respond to immune-suppressing treatment stop hoarding glucose, and the FDG signal fades or disappears.

Clinicians use this in two ways. The first is confirming the diagnosis when it was uncertain: a heart block or cardiomyopathy that improves alongside a shrinking FDG signal after treatment counts as supporting evidence under the consensus criteria (HRS expert consensus, PubMed). The second is guiding the course of treatment. A repeat scan showing no residual uptake may support a conversation about tapering; persistent or new hot spots may prompt a change of approach.

Timing varies between centers. Repeat imaging is commonly considered a few months into treatment, and again at points where a decision about continuing or stopping medicines needs to be made. Each scan requires the same careful dietary preparation, and each carries a small radiation dose, so teams try to schedule only the scans that will change a decision.

Reading serial scans has its own subtleties. Uptake can be measured semi-quantitatively, and reports may describe the intensity and extent of the signal rather than a simple yes or no. Small differences between scans can reflect variation in preparation rather than true biological change, which is another reason imaging teams insist on consistent diet instructions each time.

What a follow-up PET cannot tell you is how the heart will behave in the years ahead. It shows inflammation now. Whether a rhythm problem recurs, or pumping function recovers, depends on how much scar was already present and on factors the scan does not measure. Your team will interpret the images alongside how you feel and what your ECGs and echocardiograms show.

What are the risks of cardiac MRI and PET-CT?

Both tests are considered low-risk, but low is not zero, and the risks differ.

Cardiac MRI involves no ionizing radiation. Its main concerns are practical. The magnet can disturb or heat certain implanted devices and metal, so you will be asked in detail about pacemakers, defibrillators, surgical clips, cochlear implants and metal fragments (MedlinePlus). Many modern cardiac devices are MRI-conditional and can be scanned under supervision; older ones may not be. The scanner is enclosed and loud, and around 40 to 60 minutes of lying still with breath-holds is difficult for some people. Gadolinium-based contrast agents rarely cause allergic reactions and, in people with severely impaired kidneys, have been linked to a rare scarring condition of the skin and organs, which is why kidney function is checked beforehand.

PET-CT involves radiation from the tracer and from the CT component. MedlinePlus describes the amount from the tracer as small, and the CT for attenuation correction is typically a low-dose acquisition (MedlinePlus). The cumulative exposure across repeated scans is something your team considers when planning follow-up. Allergic reactions to FDG are very rare. The dietary preparation itself can leave people lightheaded or headachy, particularly those with diabetes, and if an anticoagulant is given before the tracer there is a small bleeding consideration the team will have assessed.

The alternative to both is not usually “no test.” It may be an echocardiogram, a longer ECG recording, a heart biopsy, or watchful monitoring. Each trades detail for simplicity or invasiveness in a different way, and the choice depends on what question needs answering and how urgently.

What people often get wrong about cardiac sarcoidosis scans

“A PET scan means they think I have cancer.” FDG PET is widely used in oncology, which is where most people first hear of it. In cardiology it is used to see inflammation, and a cardiologist ordering one is asking about granulomas, not tumors. The whole-body images may occasionally show an unexpected finding elsewhere, and if so your team will explain what it means; that possibility exists with almost any imaging.

“If the MRI is normal, my heart is fine.” MRI is excellent at showing scar, but early inflammation without scar can be subtle or invisible on MRI while still lighting up on PET. Conversely, a heart with old scar and no active disease may show a striking MRI and a dark PET. This is why the two tests are read together (HRS expert consensus, PubMed).

“The diet is just a suggestion.” It is the single biggest determinant of whether the scan can be read. A heart that took in carbohydrate glows uniformly, hiding any focal signal, and the study often has to be repeated.

“A bright spot means I definitely have cardiac sarcoidosis.” Focal uptake is suggestive, not proof. Other inflammatory conditions and incomplete suppression of normal uptake can produce similar pictures. The diagnosis rests on the combination of tissue proof of sarcoidosis somewhere, cardiac findings, and exclusion of alternatives.

“Sarcoidosis of the heart always leads to heart failure.” Outcomes vary widely. Many people have limited involvement that is managed with monitoring or a course of treatment, and some rhythm problems are handled with a device (Cleveland Clinic). No scan can forecast an individual’s path, and no article should pretend otherwise.

Questions to ask your care team before and after the scans

Consultations are short and the vocabulary is new, so it helps to arrive with questions written down. These are the ones that tend to unlock the most useful answers.

• What specific question are you hoping these scans will answer about my heart?
• Will I have both cardiac MRI and PET-CT, and in which order? What would each result change about my plan?
• Exactly what should I eat, and for how long, before the PET scan? Is there a written sheet, and whom do I call if I slip up or have diabetes?
• Do I have any implant, metal or kidney issue that affects whether I can have MRI contrast or the MRI itself?
• Will the PET scan include my whole body, and if it finds sarcoidosis elsewhere, would a biopsy there be an option?
• How will I receive the results, and roughly when? Will my case be discussed at a multidisciplinary meeting?
• If inflammation is found, what classes of treatment might be discussed, and what are the trade-offs you weigh in choosing among them?
• If scar or heart block is found, what are the considerations around a pacemaker or defibrillator in my situation?
• Will I need repeat PET scans, how often, and what would tell you that treatment is working?
• Which symptoms should prompt me to call before my next appointment, and which should send me to emergency care?
• Is there anything about my activity, work or driving that should change while we wait for answers?

Bring someone with you if you can. A second set of ears catches half of what the first set misses, and it is reasonable to ask whether you may record the conversation or receive a written summary. Good teams expect these questions; they signal a patient who will follow through on preparation and follow-up, which is exactly what makes these scans work.

When to call your doctor

Most of the time, cardiac sarcoidosis moves slowly, and the appropriate response to a new sensation is a phone call to the clinic rather than a dash to the hospital. Some signs, though, should never wait.

Call emergency services or go to the nearest emergency department if you faint or nearly faint, especially during exertion; if you have a sustained racing or pounding heartbeat that does not settle within a few minutes or comes with dizziness, chest pain or breathlessness; if you develop sudden severe shortness of breath; or if you have chest pain that is new, heavy or spreading to the arm, jaw or back (Mayo Clinic). Heart block and ventricular arrhythmias are the ways cardiac sarcoidosis most often announces itself, and both can present abruptly.

Contact your cardiology team within a day or so, without waiting for a scheduled appointment, if you notice a new pattern of palpitations or skipped beats, unexplained fatigue that limits your normal activity, swelling in the ankles or legs, breathlessness when lying flat, or a heart rate that feels unusually slow. If you have a pacemaker or defibrillator and receive a shock or an alert, report it the same day.

Around the scans themselves, call the imaging department if you develop a rash, itching, swelling or breathing difficulty after gadolinium or FDG, or if you feel faint or unwell during the dietary preparation, particularly if you have diabetes. If you have started an immune-suppressing medicine, a fever, a persistent cough or any sign of infection warrants a call, since these medicines lower your defenses (NHS). Every decision about what to do next belongs to your treating team, but the decision to pick up the phone belongs to you, and it is one you should make early rather than late.

Frequently asked questions

Is cardiac sarcoidosis serious?

It can be serious, and it can also be limited and manageable, depending on where granulomas settle in the heart. Involvement of the conduction system can cause heart block; involvement of the ventricle walls can trigger dangerous rhythms or, over time, weaken pumping. Many people have modest involvement that is monitored or treated with medicines or a rhythm device. Imaging helps your team judge which situation applies to you rather than assuming the worst.

Why would a cardiologist do a PET scan?

A cardiologist orders a PET scan to look for active inflammation in the heart muscle when a rhythm problem or weakened heart has no ordinary explanation such as blocked arteries. FDG PET shows where inflammatory cells are consuming sugar, and a paired perfusion scan maps blood flow. The whole-body images can also reveal sarcoidosis in lymph nodes or lungs, which may offer a safer biopsy site than the heart.

Is it serious if you need a PET scan?

Needing a PET scan reflects the quality of the question, not necessarily the severity of your condition. The test is ordered because inflammation is one possible explanation for your heart findings and the treatment for inflammation differs from the treatment for other causes. Many scans come back showing little or no active disease. Your cardiologist is testing an idea and avoiding a wrong treatment path, which is a careful step rather than an alarming one.

What diet should I follow before a PET scan for cardiac sarcoidosis?

Follow your imaging department’s written instructions exactly, because protocols differ. Most call for a high-fat, very low-carbohydrate diet before the scan, meaning eggs, meat, fish, cheese, oils and non-starchy vegetables while avoiding bread, rice, pasta, fruit, milk, sweetened drinks and hidden sugars, followed by a prolonged fast with water only. The aim is to switch the heart from burning sugar to burning fat so only inflammatory cells light up. Tell the team if you have diabetes.

What does an FDG PET show in cardiac sarcoidosis that MRI cannot?

FDG PET shows metabolic activity, meaning cells actively consuming glucose right now, which identifies live inflammation. MRI shows structure: scar through late gadolinium enhancement, chamber size and pumping function, and tissue swelling. A heart with early inflammation may look normal on MRI yet glow on PET, while an old scar can be vivid on MRI and dark on PET. Reading both together separates active disease from healed damage.

Can a cardiac MRI alone diagnose sarcoidosis?

No. MRI can show scar in a pattern that suggests sarcoidosis, but other conditions such as myocarditis and inherited heart muscle diseases can leave similar marks. Consensus criteria require either granulomas in a heart biopsy or proven sarcoidosis elsewhere in the body plus at least one cardiac feature, of which suggestive MRI findings are one. The MRI is a strong piece of evidence, not the whole case.

How long does a cardiac sarcoidosis PET scan take?

Plan for a few hours in the department, although the time under the camera is much shorter. After a blood glucose check and cannula placement, a perfusion scan may be done first, then the FDG tracer is injected and there is a waiting period, commonly around an hour, while it distributes. The heart and whole-body images follow. You can eat normally afterward and usually return to your day.

Is the radiation from a cardiac PET-CT dangerous?

The radiation from the tracer is described by MedlinePlus as small, and the CT portion used for anatomical mapping is typically a low-dose acquisition. The exposure is not zero, and because follow-up scans may be repeated over months, your team considers the cumulative total when planning how often to image. PET-CT is generally postponed in pregnancy. Cardiac MRI, by contrast, uses no ionizing radiation at all.

What happens if my PET scan shows the whole heart glowing?

Uniform uptake across the entire heart usually means the dietary preparation did not fully switch the muscle from sugar to fat, so healthy tissue is taking up tracer and hiding any focal signal. The report will typically describe the study as non-diagnostic or limited by incomplete suppression, and the scan is often repeated with a stricter preparation. It does not mean your whole heart is inflamed.

How is a cardiac sarcoidosis diagnosis confirmed after imaging?

Confirmation usually combines tissue and imaging. If the PET reveals an FDG-avid lymph node or lung lesion, a biopsy there can prove sarcoidosis with less risk than sampling the heart. That tissue proof, plus a cardiac feature such as patchy FDG uptake, late gadolinium enhancement, unexplained heart block or arrhythmia, meets the clinical pathway in the HRS consensus criteria. Your team also rules out mimics before settling on the diagnosis.

References

• NHS: Sarcoidosis
• MedlinePlus: PET scan
• MedlinePlus: Heart MRI

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.